Richard Schroeder
Sr. Principal Biologist, Diabetes Complications & Outcomes Research @ Eli Lilly and Company
About Richard Schroeder
Richard Schroeder is a Senior Principal Biologist specializing in Diabetes Complications and Outcomes Research at Eli Lilly and Company, where he has worked since 2018. He has extensive experience in preclinical models and has held various roles in prominent pharmaceutical companies, including Pfizer and Moderna.